Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Expert Rev Clin Immunol ; : 1-12, 2024 Mar 13.
Artigo em Inglês | MEDLINE | ID: mdl-38459764

RESUMO

INTRODUCTION: Different pathological types of colorectal cancer have distinguished immune landscape, and the efficacy of immunotherapy will be completely different. Colorectal medullary carcinoma, accounting for 2.2-3.2%, is characterized by massive lymphocyte infiltration. However, the attention to the immune characteristics of colorectal medullary carcinoma is insufficient. AREA COVERED: We searched the literature about colorectal medullary carcinoma on PubMed through November 2023to investigate the hallmarks of colorectal medullary carcinoma's immune landscape, compare medullary carcinoma originating from different organs and provide theoretical evidence for precise treatment, including applying immunotherapy and BRAF inhibitors. EXPERT OPINION: Colorectal medullary carcinoma is a pathological subtype with intense immune response, with six immune characteristics and has the potential to benefit from immunotherapy. Mismatch repair deficiency, ARID1A missing and BRAF V600E mutation often occurs. IFN-γ pathway is activated and PD-L1 expression is increased. Abundant lymphocyte infiltration performs tumor killing function. In addition, BRAF mutation plays an important role in the occurrence and development, and we can consider the combination of BRAF inhibitors and immunotherapy in patients with BRAF mutant. The exploration of colorectal medullary carcinoma will arouse researchers' attention to the correlation between pathological subtypes and immune response, and promote the process of precise immunotherapy.

2.
Discov Oncol ; 15(1): 92, 2024 Mar 31.
Artigo em Inglês | MEDLINE | ID: mdl-38555560

RESUMO

OBJECTIVE: AT-rich interaction domain 1A (ARID1A) mutant tumors show active anti-tumor immune response, which is the potential indication of immunotherapy. However, the relationship between the heterogeneous ARID1A expression and the immune response and immunotherapy efficacy in colorectal cancer (CRC) is still unclear. METHODS: We collected 1113 cases of patients with stage I-IV CRC who underwent primary resection at Harbin Medical University Cancer Hospital. ARID1A expression in CRC tissues was assessed via immunohistochemistry (IHC). CD8, CD163 and FOXP3 were stained by IHC to identify the immune landscape. Clinicopathological features of patients were compared using statistical tests like the Wilcoxon-Mann-Whitney test or χ2 tests. Kaplan-Meier survival analysis with log-rank tests were employed. RESULTS: Heterogeneous ARID1A expression was categorized into integrity expression, complete expression deficiency (cd-ARID1A), partial expression deficiency (pd-ARID1A), and clonal expression deficiency (cld-ARID1A). ARID1A-deficient expression was significant association with dMMR (P value < 0.001). Patients with ARID1A deficiency, compared to ARID1A-proficient patients, exhibited increased infiltration levels of CD8 + P value < 0.0001), CD163 + P value < 0.001), and FOXP3 + P value < 0.001).cells within the tumor tissue. However, in different subgroups, only samples with complete or partial deficiency of ARID1A showed a higher abundance of lymphocyte infiltration. In patients with ARID1A-clonal expression deficiency tumor, the infiltration patterns of three immune cell types were comparable to those in ARID1A-proficient patients. Heterogeneous ARID1A expression is related to the different prognosis and immunotherapythe efficacy in CRC patients. CONCLUSION: Heterogeneous ARID1A expression is accompanied by a different immune landscape. CRC patients with ARID1A-clonal expression deficiency do not benefit from the treatment of immune checkpoint inhibitors (ICIs).

3.
Comput Intell Neurosci ; 2022: 3543937, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-35909849

RESUMO

Monitoring environmental water quality in an efficient, cheap, and sustainable way can better serve the country's strategic requirements for water resources and water ecological protection. This paper takes the Shaanxi section of the Weihe River Basin as a pilot project and aims to use the Internet of Things technology to develop water quality monitoring sensors, so as to realize the construction of low-cost, high-reliability water quality monitoring demonstration applications. First of all, we established the design of the water quality collection terminal, designed the low-power water quality sensor node, supported the Internet of Things protocol and the collection of various water quality parameters, and used networking for data transmission. Secondly, we use the ant colony algorithm-based system clustering model to obtain a cluster map of water quality monitoring tasks in a certain section of the Weihe River Basin. We take the task clustering graph as an example for analysis, optimize the monitoring model through the ant colony algorithm, and obtain the weight of the optimization index. The weight of the scheduled task limit of the monitoring point becomes larger, so the release of the monitoring task mainly affects the limit of the scheduled task of the monitoring point. Through the above work, we designed and implemented a set of online water quality monitoring system based on the Internet of Things and data mining technology. The system can provide reference for large-scale water resource protection and water environment governance.


Assuntos
Internet das Coisas , Rios , China , Monitoramento Ambiental/métodos , Projetos Piloto , Reprodutibilidade dos Testes , Qualidade da Água
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA